Researcher profile

Wilfred Ndifon

Wilfred Ndifon contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 15 - UnverifiedVerification L1Unclaimed author
3works
0followers
4topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

3 published item(s)

preprint2023arXiv

Stochastics of DNA Quantification

A common approach to quantifying DNA involves repeated cycles of DNA amplification. This approach, employed by the polymerase chain reaction (PCR), produces outputs that are corrupted by amplification noise, making it challenging to accurately back-calculate the amount of input DNA. Standard mathematical solutions to this back-calculation problem do not take adequate account of such noise and are error-prone. Here, we develop a parsimonious mathematical model of the stochastic mapping of input DNA onto experimental outputs that accounts, in a natural way, for amplification noise. We use the model to derive the probability density of the quantification cycle, a frequently reported experimental output, which can be fit to data to estimate input DNA. Strikingly, the model predicts that a sample with only one input DNA molecule has a $<$4% chance of testing positive, which is $>$25-fold lower than assumed by a standard method of interpreting PCR data. We provide formulae for calculating both the limit of detection and the limit of quantification, two important operating characteristics of DNA quantification methods that are frequently assessed by using ad-hoc mathematical techniques. Our results provide a mathematical foundation for the rigorous analysis of DNA quantification.

preprint2020arXiv

A strategy for finding people infected with SARS-CoV-2: optimizing pooled testing at low prevalence

Suppressing SARS-CoV-2 will likely require the rapid identification and isolation of infected individuals, on an ongoing basis. RT-PCR (reverse transcription polymerase chain reaction) tests are accurate but costly, making regular testing of every individual expensive. The costs are a challenge for all countries and particularly for developing countries. Cost reductions can be achieved by combining samples and testing them in groups. We propose an algorithm for grouping subsamples, prior to testing, based on the geometry of a hypercube. At low prevalence, this testing procedure uniquely identifies infected individuals in a small number of tests. We discuss the optimal group size and explain why, given the highly infectious nature of the disease, parallel searches are preferred. We report proof of concept experiments in which a positive sample was detected even when diluted a hundred-fold with negative samples. Using these methods, the costs of mass testing could be reduced by a factor of ten to a hundred or more. If infected individuals are quickly and effectively quarantined, the prevalence will fall and so will the costs of regularly testing everyone. Such a strategy provides a possible pathway to the longterm elimination of SARS-CoV-2. Field trials of our approach are now under way in Rwanda and initial data from these are reported here.

preprint2011arXiv

Supporting information for: New methods for analyzing serological data with applications to influenza surveillance

For decades, the hemagglutination-inhibition (HI) assay has been used in epidemiological and basic biological studies of influenza viruses. The mechanistic basis of the assay results (called titers) is not well understood. The first part of this document describes a biophysical model of HI that illuminates the mechanistic basis of and provides the theoretical motivation for new ways of interpreting titers. The biophysical model is applicable to other serological assays; this fact is illustrated using the neutralization assay. The second part of the document describes some new ways of interpreting titers, which involve, among other methods, singular value decomposition and probabilistic multidimensional scaling. The third part of the document discusses biological and mathematical issues related to the determination of the effective dimensionality of titers, and describes an algorithm for recovering unavailable titers.